Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kymera Therapeutics (KYMR) Prepaid Assets: 2019-2024

Historic Prepaid Assets for Kymera Therapeutics (KYMR) over the last 6 years, with Dec 2024 value amounting to $20.6 million.

  • Kymera Therapeutics' Prepaid Assets rose 29.77% to $22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.6 million, marking a year-over-year increase of 29.77%. This contributed to the annual value of $20.6 million for FY2024, which is 76.26% up from last year.
  • Kymera Therapeutics' Prepaid Assets amounted to $20.6 million in FY2024, which was up 76.26% from $11.7 million recorded in FY2023.
  • Kymera Therapeutics' Prepaid Assets' 5-year high stood at $20.6 million during FY2024, with a 5-year trough of $4.7 million in FY2020.
  • Moreover, its 3-year median value for Prepaid Assets was $11.7 million (2023), whereas its average is $14.0 million.
  • Data for Kymera Therapeutics' Prepaid Assets shows a peak YoY surged of 429.73% (in 2020) over the last 5 years.
  • Over the past 5 years, Kymera Therapeutics' Prepaid Assets (Yearly) stood at $4.7 million in 2020, then surged by 85.37% to $8.7 million in 2021, then rose by 11.39% to $9.7 million in 2022, then grew by 20.19% to $11.7 million in 2023, then surged by 76.26% to $20.6 million in 2024.